Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Acq. announced
Appointed director
Akili, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 SC 13D/A Palihapitiya Chamath reports a 17.6% stake in Akili, Inc.
10/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Akili Announces Leadership Transition"
10/02/2023 EFFECT Form EFFECT - Notice of Effectiveness:
09/27/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/10/2023 8-K Quarterly results
Docs: "Akili Reports Second Quarter 2023 Financial Results and Provides Business Update"
06/07/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
06/07/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Akili Releases EndeavorOTC TM Video Game Treatment to Improve Attention in Adults with ADHD"
05/12/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/12/2023 8-K/A Quarterly results
Docs: "Akili Reports First Quarter 2023 Financial Results and Provides Business Update"
05/11/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/11/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Akili Reports First Quarter 2023 Financial Results and Provides Business Update"
05/04/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/04/2023 8-K Quarterly results
03/22/2023 ARS Form ARS - Annual Report to Security Holders:
03/22/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/22/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/21/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/09/2023 10-K Annual Report for the period ended December 31, 2022
03/07/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
03/07/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update"
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 0% stake in Akili, Inc.
02/07/2023 SC 13G/A MILLENNIUM MANAGEMENT LLC reports a 3.3% stake in AKILI, INC.
01/20/2023 SC 13G BAILLIE GIFFORD & CO reports a 6% stake in AKILI, Inc.
01/12/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
01/12/2023 8-K Cost Associated with Exit or Disposal Activities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ...
Docs: "Akili, Inc. Chief Executive Officer Email to Employees, January 12, 2023"
01/05/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
01/05/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Pivotal Trial of EndeavorRx ® in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes"
10/27/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy